Publication date: 1 June 2018
Source:Cell Stem Cell, Volume 22, Issue 6
New technologies are revolutionizing the potential of hematopoietic stem cell transplantation (HSCT) to effectively treat many hematologic disorders and malignancies. Here we chat with Dr. Luigi Naldini about the remaining challenges for successful transplantation, cutting-edge new technologies, and what exciting breakthroughs he looks forward to seeing on the horizon.
https://ift.tt/2Lhv3Ue
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,
Ετικέτες
Παρασκευή 1 Ιουνίου 2018
Ask the Expert: Luigi Naldini
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Summary Insulinomas are rare neuroendocrine tumours that classically present with fasting hypoglycaemia. This case report discusses an un...
-
The online platform for Taylor & Francis Online content New for Canadian Journal of Remote Sen...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου